Ideas – Page 151

January 23, 2019

Published by admin_auro at January 23, 2019

Categories

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA; Paul F. Glenn Center […]

January 23, 2019

Published by admin_auro at January 23, 2019

Categories

Probiotic-based therapy for body weight control, energy homeostasis, and TIIDM: Probiotic Lactobacillus Pentosus var. Plantarum C29 increases REV-ERB and its downstream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 23/January/2019, 9.57 am

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]

January 22, 2019

Published by admin_auro at January 22, 2019

Categories

Combinatorial therapy for Deafness: A therapeutic mix encompassing Lactobacillus plantarum AR501, Cholecalciferol, Ajoene and DIM (LPARCAD) increases the expression of ATG5 (Autophagy-ated 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration, improves hearing loss via up regulation of its target genes, 23/January/2019, 12,04 am

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Combinatorial therapy for Deafness: A therapeutic mix encompassing Lactobacillus plantarum AR501, Cholecalciferol, Ajoene and DIM (LPARCAD) increases […]

January 22, 2019

Published by admin_auro at January 22, 2019

Categories

Ribonucleic acid-based therapy for autoimmune diabetes: LncRNA CASC9 increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 22/January/2018, 11.35 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical […]